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Abstract
Background: The neurocircuits that process somatic sensory information in the dorsal horn of the spinal cord are
still poorly understood, with one reason being the lack of Cre lines for genetically marking or manipulating
selective subpopulations of dorsal horn neurons. Here we describe Tac2-Cre mice that were generated to express
the Cre recombinase gene from the Tac2 locus. Tachykinin 2 (Tac2) encodes a neurotransmitter, neurokinin B (NKB).
Results: By crossing Tac2-Cre mice with ROSA26-tdTomato reporter mice, we directly visualized Tac2 lineage
neurons in the dorsal root ganglia, the dorsal horn of the spinal cord, and many parts of the brain including the
olfactory bulb, cerebral cortex, amygdala, hippocampus, habenula, hypothalamus, and cerebellum. This Tac2-Cre
allele itself was a null allele for the Tac2 gene. Behavioral analyses showed that Tac2 homozygous null mice
responded normally to a series of algogenic (pain-inducing) and pruritic (itch-inducing) stimuli.
Conclusions: Tac2-Cre mice are a useful tool to mark specific subsets of neurons in the sensory ganglia, the dorsal
spinal cord, and the brain. These mice can also be used for future genetic manipulations to study the functions of
Tac2-expressing neurons or the functions of genes expressed in these neurons.
Background
The spinal cord dorsal horn has long been recognized as
the processing center for sensory information including
pain, itch, cold, and warmth [1-4]. The dorsal horn is
divided into five laminae, which can be identified by
lamina-specific innervation by primary sensory fibers
and by the expression of molecular markers [3]. For
example, neurons in superficial laminae that express the
neurokinin 1 receptor (NK1R) and the gastrin-releasing
peptide receptor (GRPR) are involved in sensing pain
and/or itch [5-7]. Neurons in the inner layer of lamina
II that express protein kinase C g (PKCg) are the targets
of myelinated non-nociceptive afferents [8], and mediate
nerve injury-induced mechanical allodynia, a type of
pain evoked by innocuous mechanical stimuli [9].
Despite significant progress, the neural circuits that pro-
cess specific somatic sensory information in the dorsal
horn are still not well characterized [3].
Tachykinin peptides are encoded by the tachykinin 1
(Tac1)a n dtachykinin 2 (Tac2) genes and are known to
modulate neuronal activity [10]. Tac1 encodes a precur-
sor protein that produces two peptides, substance P (SP)
and neurokinin A (NKA), whereas Tac2 encodes neuro-
kinin B (NKB). Release of SP from sensory neurons in
the dorsal root ganglia (DRG) plays a crucial role in
modulating pain and itch [11-13]. More specifically,
mice lacking Tac1 fail to sense moderate to intense
thermal and mechanical pain [11]. Tac2 expression has
also been detected in restricted neuronal populations in
the central nervous system [14-16]. In the dorsal spinal
cord, for example, Tac2 was detected in lamina I and
the inner layer of lamina II of both mouse and rat dor-
sal horns [14-16]. Consistently, it has been suggested
that activation of NK3R, the NKB receptor, plays a role
in pain modulation [17-19].
The Cre-loxP recombinase system has become a
powerful tool to study the morphology and function of
specific neuronal populations. An exemplary triumph is
the creation of Cre mouse lines that mark distinct sub-
sets of primary sensory neurons, which allowed precise
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thus have provided unprecedented insight into the cellu-
lar basis of pain and itch [20-23]. The availability of
additional precise and neuron-specific Cre lines will
allow more such discoveries, especially in light of gen-
ome-wide conditional knockout resources [24]. To study
the physiological function of Tac2, and to characterize
Tac2-expressing neurons, here we report the generation
of Tac2-Cre mice in which Cre recombinase is under
the control of the Tac2 locus, and where Tac2-Cre
represents a null allele.
Results
Generation of Tac2-Cre mice
The targeting strategy used to generate Tac2-Cre mice is
illustrated in Figure 1. In the targeting vector, Cre and a
neomycin selection cassette were inserted into exon 3,
the first coding exon of Tac2. The neomycin selection
cassette is floxed with FRT sites that can be removed
later by Flipase-mediated DNA recombination [25].
After electroporation in 129/Sv embryonic stem cells,
192 clones that survived selection with Geneticin were
screened via Southern blot analysis, and 9 correctly tar-
geted clones were identified. The digestion of genomic
DNA with the restriction enzyme XbaI generated a12Kb
fragment for the wildtype allele, and two different 7 Kb
fragments for the Tac2-Cre mutant allele, depending on
whether the 5’ or 3’ arm external probe was used (Fig-
ure 1). Two positive cell lines were used for blastocyst
injection and the resulting chimera mice were crossed
with C57BL6 wildtype mice. F1 progenies carrying germ
line transmission of the Tac2-Cre allele were identified,
which were then crossed to FLPeR mice to delete the
neomycin cassette [25].
Tac2-Cre expression in the dorsal spinal cord
To analyze the efficiency and fidelity of Cre recombinase
activity, Tac2-Cre mice were crossed to the Cre-depen-
dent reporter line ROSA26-loxP-STOP-loxP-tdTomato
[26]. The resulting double heterozygous mice (Tac2-Cre;
ROSA26-loxP-STOP-loxP-tdTomato)w i l lb er e f e r r e dt o
as Tac2-Cre/Tomato mice, in which Cre-mediated
recombination led to constitutive expression of the red
fluorescent protein Tomato. As a result, neurons that
expressed Tac2-Cre, either transiently or persistently,
were permanently marked by Tomato expression.
In the dorsal spinal cord of Tac2-Cre/Tomato mice,
Tomato expression was first detected at postnatal day 4,
similar to in situ expression analysis ([27], data not
shown). By P30, Tomato-positive neurons were observed
mainly within the ventral layer of inner lamina II and
lamina III (Figure 2A, big arrow; Figure 2B), as they
were located ventral to primary sensory terminals
labeled by isolectin-B4 (IB4) that innervate the dorsal
layer of inner lamina II (Figure 2C) [8]. A few scattered
Tomato-expressing cells were also observed in more
ventral spinal areas (Figure 2A, small arrow). Further-
more, the processes of these Tomato-positive neurons
were short and remained within the narrow laminae
(Figure 2B, small arrow; Figure 2E, small arrow), sug-
gesting their role in processing local information. Occa-
sionally, Tomato-expressing neurons were also found in
lamina I (Figure 2B, arrowhead), and they exhibited
long, transverse processes (Figure 2D). This lamina-spe-
cific distribution of Tac2-Cre/Tomato neurons is consis-
tent with the reported distribution of Tac2 mRNA and
NKB peptide [14-16,27].
To further examine efficacy and specificity, we per-
formed double staining of the Tomato protein and Tac2
mRNA, transcribed from the wildtype allele and
detected by in situ hybridization, on spinal sections of
P30 Tac2-Cre/Tomato heterozygous mice. We found
Tomato reporter expression in the majority (169/209,
81%) of neurons with detectable Tac2 transcripts (Figure
2E, arrow), demonstrating that Tac2-Cre was able to
drive efficient DNA recombination in most Tac2-expres-
sing neurons. However, we also found that a significant
number of Tomato-expressing dorsal horn neurons
failed to show detectable Tac2 mRNA expression (Fig-
ure 2E, arrowhead). Notably, the Tac2-negative,
Tomato-positive neurons intermingled with Tac2-posi-
tive neurons in the same dorsal horn laminae (Figure
2E). Thus, some dorsal horn neurons expressed Tac2
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Figure 1 Generation of Tac2-Cre mice. Top, schematic diagram of
the gene targeting strategy used to insert Cre into the wildtype
Tac2 locus. The Tac2-Cre targeting vector included Cre directly
downstream of the Tac2 ATG codon sequence, an FRT-flanked
neomycin positive selection cassette, and a DTA negative selection
cassette. XbaI sites and the expected sizes of the resulting DNA
fragments are indicated. Below, Southern blot analyses for
verification of correct targeting of Tac2 locus. Southern blot with
XbaI and external probes confirmed correctly targeted homologous
recombination events. The 12 kb WT band is seen in all lanes, and
two correctly targeted and distinct 7 Kb bands represent the
targeted allele at the 5’ and 3’ homology arms.
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Figure 2 Characterization Tac2-Cre expressing neurons in the dorsal horn of the spinal cord. A: A transverse section through a P30 spinal
cord showing fluorescent Tomato expression enriched in dorsal horn neurons as indicated by the large arrow. Small arrow indicates sporadic
Tomato-positive neurons in the deep dorsal horn. B: Enlarged inset of the dorsal horn (A), showing Tomato-positive neurons in lamina I
(arrowhead), as well as the ventral layer of inner lamina II and lamina III (large arrow). Note the local processes in lamina II/III (small arrow). C:
Double staining of Tomato fluorescence (red) and fluorescently conjugated isolection IB4 (green). Tomato-positive neurons are located ventral to
the dorsal layer of inner lamina II marked by IB4-positive sensory terminals. D: Transverse section of a P10 spinal cord illustrating a lamina I
neuron with long processes. E: Co-localization of Tomato and Tac2 transcripts. Sections were first photographed for Tomato fluorescence (red),
then used to conduct in situ hybridization (pseudo-colored green), and the resultant signals were merged. Large arrow indicates a neuron co-
expressing Tomato and Tac2 mRNA, while arrowhead indicates one that expressed Tomato but not Tac2 mRNA. Small arrow indicates neuronal
processes within inner lamina II and lamina III. F-H: Double staining of Tomato (red) and antibodies (green) against PKCg (F), Tlx3 (G), and Pax2
(H). Arrows mark double-positive neurons and arrowheads mark Tomato-positive neurons that did not co-express PKCg (F) or Tlx3 (G).
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dard in situ hybridization techniques, although we can-
not rule out the possibility that inserting Cre within the
Tac2 coding sequence led to ectopic expression of
Tac2-Cre.
Next, we conducted molecular analysis on these Tac2-
Cre/Tomato neurons. PKCg is expressed by neurons
within ventral layer of inner lamina II, and 20% (32/160)
of Tomato-positive neurons of Tac2-Cre/Tomato mice
clearly expressed PKCg (Figure 2F, arrow). The remain-
ing Tomato-expressing neurons were located in areas
that exhibited weak PKCg staining (Figure 2F, arrow-
head). This weak PKCg staining may be indicative of
weak PKCg expressing neurons, or represent axonal or
dendritic processes derived from adjacent strong PKCg-
expressing neurons. If the latter is true, this subset of
Tomato-positive neurons may not express PKCg per se,
but instead connect with PKCg-expressing neurons.
We reported previously that Tac2 mRNA in the dorsal
horn is mainly detected in glutamatergic excitatory neu-
rons marked by the expression of Tlx3, a homeobox
protein [27]. Consistent with this, most Tac2-Cre/
Tomato-positive neurons (85%, 167/197) continued to
express Tlx3 (Figure 2G, arrow) [27,28], and almost
none of the Tac2-Cre/Tomato-positive neurons co-
expressed Pax2 (2%, 2/131), a marker of inhibitory neu-
rons (Figure 2H, green) [28].
Tac2-Cre/Tomato expression in the brain
Tomato-positive neurons were detected in multiple
brain regions as shown in a sagittal brain section of a
P30 Tac2-Cre/Tomato mouse (Figure 3), and this result
is largely consistent with previous expression analyses
[14,15]. Within the main olfactory bulb, Tomato labeled
neurons were located within the periglomerular layer
(Figure 3A, B) and the granule layer (Figure 3A, C).
Notably, labeled neurons in the granule layer sent long
apical dendrites (Figure 3C), a morphology typical of
inhibitory granule cells as reviewed by Shepherd et al.
[29]. In the cerebral cortex, Tomato fluorescence was
enriched in layers II and III, but was also found scat-
tered through other cortical layers (Figure 3A, D). These
neurons showed pyramidal shaped soma with long den-
drites toward the apical surface (Figure 3D), a morphol-
ogy typical of glutamatergic projection neurons [30]. In
the hippocampus, Tomato was expressed in the granule
cell layer of the dentate gyrus and the pyramidal cell
layer of the CA1-CA3 regions (Figure 3A, E, Figure 4A).
Other Tomato-expressing neurons were observed in the
bed nuclei of the stria terminalis (Figure 3A, G), the
granule cells in the cerebellum (Figure 3A, H), and the
superficial laminae of the spin a lt r i g e m i n a ln u c l e i( F i g -
ure 3A, I). Furthermore, a coronal section demonstrated
Tomato expression in the medial habenula (Figure 4A,
B), amygdala nuclei (Figure 4A, C), and scattered neu-
rons in hypothalamic nuclei including the arcuate
nucleus (Figure 4A, D). In contrast, Tomato expression
was rarely detected in other brain regions such as the
thalamus (Figure 3A, F).
Tac2-Cre/Tomato expression in the peripheral nervous
system
Within the peripheral nervous system, Tac2-Cre/Tomato
was detected in a small subset of neurons in the DRG
(Figure 5A) and in the sympathetic ganglia (data not
shown). This is surprising because detection of Tac2
mRNA in adult DRG has not yet been reported ([10,14],
data not shown). Given Tomato reporter expression was
present at P0 (data not shown), these neurons might
express Tac2 transiently during embryonic development.
Interestingly, these Tomato-positive neurons innervated
selective peripheral targets (Figure 5B-D). Wholemount
preparations revealed Tomato-positive fibers in the glab-
rous skin (Figure 5B), and as shown in a transverse sec-
tion, these fibers were located within the dermal layer
(Figure 5C). In the colon, a visceral organ, thin circum-
ferential Tomato-positive fibers were detected in the
muscle layer (Figure 5D), and Tac2-Cre expression was
also detected in the bladder (data not shown).
Tac2 null mice responded normally to pain-related or
itch-related stimuli
In Tac2-Cre mice, the Cre expression cassette, which
contained the HSV thymidine kinase polyA signal, was
inserted directly after the first ATG codon of the Tac2
gene, thereby creating a null allele. Consistent with this,
we demonstrated a loss of Tac2 expression in the dorsal
spinal cord of mutant mice (Figure 6A). In contrast, a
control in situ hybridization using the somatostatin
probe showed comparable signals in mutant versus con-
trol littermates (Figure 6A). Tachykinin peptides, such
as SP and NKA, have been implicated in modulating
pain and itch [11-13,31]. Therefore we sought to deter-
mine if Tac2 also played a role in modulating pain and/
or itch sensation. Tac2
Cre/Cre homozygous null mice sur-
vived at the expected Mendelian ratio. We performed a
series of pain and itch behavior assays on these mutant
mice, using wildtype or Tac2
Cre/+ heterozygous litter-
mates as controls. In comparison to control mice,
Tac2
Cre/Cre homozygous null mice responded normally
to painful stimuli, including noxious heat (48°C, 50°C,
52°C, 54°C, 56°C, 58°C, Figure 6B), light mechanical sti-
muli (von Frey assay, Figure 6C), intense mechanical sti-
muli (Randall-Selitto; Figure 6D), and chemical stimuli
(formalin, Figure 6E). Moreover, like control littermates,
Tac2
Cre/Cre homozygous null mice showed similar
scratching responses following nape injection of itching
compounds [23,32,33], including Compound 48/80
Mar et al. Molecular Brain 2012, 5:3
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Page 4 of 11(Figure 6F), PAR2 agonist (Figure 6G), chloroquine (Fig-
ure 6H), and serotonin (Figure 6I).
Discussion
We have generated a Tac2-Cre knock-in mouse line that
drives Cre recombinase expression in various parts of
the nervous system, including sensory neurons innervat-
ing skin dermis and visceral organs, a subset of excita-
tory neurons in the dorsal spinal cord, interneurons in
the olfactory bulb, projection neurons in the cerebral
cortex, neurons in specific amygdala nuclei, granule cells
in the dentate gyrus, pyramidal neurons in the
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Figure 3 Tac2-Cre-expressing neurons in multiple brain regions. A sagittal section of a P30 adult Tac2-Cre/ROSA26-tdTomato brain (A)
showing Tomato positive neurons were located within the olfactory bulb (B, C), cortex (D), hippocampus (E), bed nuclei of the stria terminalis
(G), cerebellum (H), medulla (I), but not in all the brain regions, such as the thalamus (F, arrow). Arrowhead and arrow in E indicate the dentate
gyrus and the CA1-CA3 regions of the hippocampus, respectively. Scale bar, 50 um.
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ebellum, and others. Thus, this Cre line will be of broad
utility to the neuroscience community.
In the dorsal spinal cord, Tac2-Cre is expressed in the
ventral layer of inner lamina II and lamina III, and occa-
sionally in lamina I and in more ventral spinal areas
(Figure 2A, B). Tac2-Cre neurons in the dorsal horn are
excitatory in nature and are associated with strong or
weak PKCg expression. Overall, Cre expression in Tac2-
Cre mice is precise and efficient in those neurons with
persistent Tac2 expression, as demonstrated by double
staining results (Figure 2B). However, the lineage tracing
experiments also revealed a set of spinal neurons and
peripheral sensory neurons that might express Tac2
transiently.
The expression pattern of Tomato in the dorsal horn
of Tac2-Cre/Tomato mice is largely consistent with
existing literature, but also differed in a few of respects
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Figure 4 Tac2-Cre neurons located in additional brain regions. A transverse section of a P30 adult Tac2-Cre/ROSA26-tdTomato brain showing
Tomato-positive neurons (A). Note Tomato expression within the medial habenula (B, “MH”), with processes projecting ventral laterally (B,
arrowhead). Tomato expression was also detected in the medial amygdalar nucleus (C, “MEA”), and the arcuate hypothalamic nucleus (D, “ARH”).
Scale bar, 50 um.
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rat dorsal horn [16]. For example, whereas many NKB-
immunostained neurons were observed in dorsal horn
lamina I in rat [16], Tomato-positive neurons were only
occasionally seen in lamina I of Tac2-Cre/Tomato mice
(Figure 2B), consistent with in situ expression analyses
[14,27]. This discrepancy could be due to species differ-
ence and/or the binding of the NKB antibody to certain
NKB-negative neurons.
One notable feature of this Tac2-Cre mouse line, at
least in the dorsal spinal cord, is the post-natal onset of
Tac2-Cre expression (from P4-P10). Consequently, con-
ditional knockouts in combination with this Cre line
will be useful for studying the roles of interested genes
in controlling postnatal development of neural circuits
or controlling physiological functions of dorsal horn
neurons.
Several recent genetic marking studies have led to
identification of somatic sensory neurons that innervate
specific peripheral targets. For example, MrgprD-expres-
sing polymodal nociceptors, representing 30% of DRG
neurons, innervate exclusively skin epidermis [34,35].
Similarly, MrgprB4-expressing neurons innervate skin
epidermis around the hairs [36]. To our knowledge,
Tac2-Cre/Tomato may represent the first molecular
marker of a small subset of DRG neurons that innervate
selective deep tissues, such as the dermis and visceral
organs.
Behavioral studies suggested that the loss of Tac2 did
not result in a detectable effect on pain or itch sensa-
tion, at least based on the assays used in this study. This
finding is surprising considering that intrathecal injec-
tion of NKB or NK3R agonist has been reported to
cause hyperalgesia [18,19] or hypoalgesia [17]. However,
it is consistent with observations that no obvious pain
deficits had been reported in NK3 knockout mice
[37-39]. Perhaps the lack of behavioral deficit in Tac2
null mice is the result of redundant function with SP
and NKA. Future studies on mice that lack both Tac1
and Tac2 could be informative in this regard.
Conclusions
The Tac2-Cre knock-in mouse line is able to mark Tac2
lineage neurons in the dorsal root ganglia, the dorsal
spinal cord and various parts of the brain. Thus, this
Cre line will be a useful genetic tool for conditionally
manipulating genes in selective populations of neurons.
Methods
Generation of Tac2-Cre targeting Construct
A 10 Kb EagI/XbaI fragment, containing all 8 exons of
the Tac2 gene, was subcloned from the BAC RP23-
270B22 (UCSC Mus musculus Genome Brower). Next,
the Cre coding sequence with a polyA signal was
inserted in-frame with the first ATG of the Tac2 coding
sequence. Finally, an FRT flanked neomycin cassette was
inserted downstream of the Cre cassette. The orientation
and sequence of the targeting construct was confirmed
by sequencing.
Generation of Tac2-Cre mice
The targeting construct was linearized using NotI and
electroporated into 129/Sv embryonic stem (ES) cells.
ES cells were drug selected using geneticin and correctly
targeted clones were identified using Southern blot ana-
lysis. Genomic DNA was extracted from 96 well colo-
nies, digested with XbaI, Southern blotted, and
hybridized using both 5’ and 3’ arm external probes.
Correctly targeted Tac2 alleles exhibited two distinct 7
kb targeted bands, in contrast to the 12 Kb wildtype
band. Correctly targeted clones were used by the Dana-
Farber ES cell core facility to generate transgenic mice
via blastocyst injection. After establishing germ-line
transmission, the neomycin cassette was excised by
crossing to an FLP deleter strain [25] to generate the
Tac2-Cre mouse line. Genotyping for the Tac2-Cre wild-
type and mutant alleles was performed using PCR with
Tac2 sense, Tac2 antisense, and Cre primers. Primer
sequences were as follows: Tac2 sense primer (5’ -a t c -
caacgctcttgagatcagggctcagat - 3’), Tac2 antisense primer
(5’-ggacatcttaccttactgag-3’), Cre primer (5’-tcgaccggtaatg-
caggcaa-3’). The product sizes were as follows: wildtype
allele, Tac2 sense and antisense: 256 bp; mutant allele,
Tac2 sense and Cre: 216 bp. Products were electrophor-
esed on 1.5% agarose gels, stained with ethidium bro-
mide and photographed.
Animals
Heterozygous or homozygous Tac2-Cre mice were
crossed to heterozygous or homozygous ROSA26-tdTo-
mato mice (Madisen et al., 2010). Offspring were geno-
typed by PCR for Tac2-Cre and ROSA26-tdTomato
!"#$
Figure 5 Tac2-Cre-expressing neurons in the DRG and their
innervation of peripheral targets. Adult Tac2-Cre/ROSA26-
tdTomato mice showed fluorescence labeling in a small subset of
lumbar DRG neurons (A). Their primary afferents innervated the
glabrous skin in a wholemount preparation (B), and a transverse
section showed selective innervation within the dermal layer (C,
arrow). “derm": dermis and “epi": epidermis, and the solid arrow
indicates boundary between dermis and epidermis. In a transverse
section of the colon, Tomato-positive fibers were detected in the
muscle layer (D, “mus”), by not in the mucousal layer (D, “muc”).
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Figure 6 Tac2 Mutant mice did not exhibit defects in pain and itch sensation. A: In situ hybridization analyses of wildtype and mutant
spinal cords using Tac2 and somatostatin antisense probes demonstrated the loss of Tac2 expression in mutant mice, while the expression of
the somatostatin neuropeptide gene was unaffected. B-I: Responses to nociceptive and pruritic stimuli were normal in homozygous Tac2-Cre
mice. Mutant (mut) Tac2-Cre mice were indistinguishable from wildtype (wt) littermates in terms of latency of hindpaw withdrawal upon
application of various noxious temperatures (B, p = 0.19, 0.33, 0.09, 0.71, 0.39, 0.40; 3 female controls, 3 male controls, 4 female mutants, 3 male
mutants); in mechanical threshold for eliciting hindpaw withdrawal following application of graded pressure by von Frey fibers (C, p = 0.48; 12
female controls, 7 male controls, 9 female mutants, 12 male mutants), and to the tail by the Randall-Selitto apparatus (D, p = 1.0; 3 female
controls, 2 female mutants, 2 male mutants). Licking and biting responses to hindpaw formalin injections were unaffected in the first phase, the
first 10 minutes post-injection, and the second phase, 10-60 minutes post-injection (E, p = 0.32; 4 female controls, 3 male controls, 5 female
mutants, 2 male mutants). Furthermore, there was no significant difference in itch-related scratching responses following administration at the
indicated dosages of pruritic agents including Compound 48/80 (F, p = 0.65; 4 female controls, 1 male control, 4 female mutants, 4 male
mutants); PAR2 agonist (G n =8 ;p = 0.29; 8 female controls, 8 male controls, 8 female mutants, 8 male mutants); Chloroquine (H, p = 0.64; 4
female controls, 4 female mutants, 3 male mutants); and Me-5-HT (I, p = 0.33; 8 female controls, 8 male controls, 8 female mutants, 8 male
mutants).
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tdTomato mice at P30 were used in immunohistochem-
ical studies. Eight-week-old homozygous Tac2-Cre and
control littermate mice were used in behavior analyses.
The Institutional Animal Care and Use Committee at
Dana-Farber Cancer Institute approved all experimental
and behavioral test procedures.
In situ hybridization (ISH) and Immunostaining
ISH procedure of the Tac2 probe was previously
described [27,40]. Briefly, mice were deeply anesthetized
and perfused through the left cardiac ventricle with a
fixative containing 4% freshly depolymerized paraformal-
dehyde (4% PFA). Spinal cords were dissected and fixed
overnight in 4% PFA, equilibrated overnight with 20%
sucrose, and frozen in OCT (O.C.T. Compounds, BDH)
on dry ice. 12 uM sections were prepared and gently
permeated by Proteinase K, treated with triethanola-
mine, and hybridized with 1-2 μg/mL of DIG labeled
antisense probe for over 12 hours. Non-specific binding
was washed away by 0.2xSSC stringency at 60°C,
blocked by sheep serum and incubated with Alkaline
phosphatase conjugated anti-DIG antibody. Alkaline
phosphate reaction was catalyzed by NBT and BCIP
(Roche). For tdTomato/ISH double staining, the Tomato
fluorescent signal was directly photographed followed by
performing ISH. The ISH signals were pseudocolored
and then overlayed with the Tomato signal.
Immunohistochemical Analyses
Tissues were collected, fixed, and frozen as for ISH. 12
μm cryosections were dried at room temperature for 30
min and then fixed with 4% PBS-buffered paraformalde-
hyde solution for 10 min on ice. After three washes in
PBS, sections were incubated for 30 min in 10% goat
serum diluted in PBS containing 0.3% Triton X-100
(PBST), and for 1 h at room temperature in 1:200 biotin
conjugated IB4 (10 mg/ml, Sigma, USA) or 1:1000 dilu-
tion of a rabbit aPKCg antibody (SC-211, Santa Cruz), a
1:1000 dilution of a guinea pig aTlx3 antibody (a gift
from C. Birchmeier, Germany), or a 1:1000 dilution of a
rabbit a-Pax2 antibody (SC-211, Santa Cruz). Following
three washes in PBST, the sections were incubated for 1
h in a 1:200 dilution of Alexa Fluor 488-Streptavidin
(Invitrogen), Alexa Fluor 488-Goat-a-Guinea Pig (Invi-
trogen), or Alexa Fluor 488-Goat a-Rabbit (A11034,
Invitrogen). After three washes in PBST, the sections
were mounted in 90% glycerol, 0.5% N-propyl gallate
(pH 8.0) and analyzed using a fluorescent microscope.
Behavioral measurements
The experimenter was blind to which group an animal
belonged.
H o tP l a t et e s t :n a ï v e ,a w a k e ,a n du n r e s t r a i n e dm i c e
were individually removed from their home cage and
placed on a metal surface pre-heated and maintained at
the indicated temperatures (IITC Model PE34M-HC).
T h em i c ew e r ee n c l o s e dw i t h i nt r a n s p a r e n t2 0c mh i g h
walls, in a 14 × 14 cm area Plexiglas chamber. The
latency to performing a hindpaw flutter/shake, lick, or
jump (whichever occurred first) was measured to the
nearest 0.1 s. The cut-off time for 48-52°C was 60 sec-
onds, while for 54-58°C it was 30 seconds.
von Frey threshold: awake, unrestrained, and acclima-
tized mice were individually removed from their home
cage and habituated for 30 min in a metal mesh enclo-
sure for 2 days. Mechanical sensitivity threshold of the
stimulated hindpaw was measured for the next 2 conse-
cutive days. Mechanical sensitivity was measured by
determining the median 50% foot withdrawal threshold
(measured in mN of discrete bending force), when a sin-
gle prick to the hindfoot was applied steadily (>1 s dura-
tion) with a von Frey monofilament via the up-down
method.
Randall-Selitto: A Randall-Selitto apparatus (Ugo
Basile, Italy) was used to measure the withdrawal
threshold. The animals were restrained in plastic enclo-
sures and treated gently during the experiments. A
cone-shaped pusher with a rounded tip (diameter of the
base: 9 mm) was applied to the tail. The intensity of
pressure causing an escape reaction was defined as the
withdrawal threshold. Measurements were performed 3
times at intervals of several minutes, and the mean
value was taken as the threshold.
Formalin test: awake, unrestrained, and acclimatized
mice were individually removed from their home cage
and habituated for 30 min in mesh enclosures. Then, 25
μL of 5% formalin was injected subcutaneously into the
plantar surface of the right hindpaw using a 0.5 mL
insulin syringe with a 28G1/2 needle. Mice were then
returned to the mesh enclosure, and behavioral observa-
tions were video taped. Video recording was subse-
quently played back, and the total time spent licking
and/or biting the right hindpaw over the next 60 min-
utes was recorded to the nearest second in 5-min
blocks. The early/acute phase was defined as 0-10 min
post-injection, and the late/tonic phase as 10-60 min
post-injection.
Itch assay: awake and unrestrained mice were indivi-
dually removed from their home cage and acclimatized
for 1 hour daily, for 5 continuous days, in Plexiglas con-
tainers (10 × 10 × 12 cm) atop a glass floor. At least
two days before the injections, the nape of the neck
(approximately 15 × 10 mm area) was shaved after brief
anesthesia with isoflurane (2% in 100% oxygen). During
the experiment, a camcorder (Sony Model DCR-SR220)
Mar et al. Molecular Brain 2012, 5:3
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of mice. 100 μg of Compound 48/80 (Sigma-Aldrich),
100 μgo fP A R 2a g o n i s tS L I G R L - N H 2 (Bachem), or 30
μg of serotonin agonist a-Me-5-HT (Tocris) in 50 μlo f
sterile saline was injected intradermally into the nape
using a 0.5 ml insulin syringe with a 28G1/2 needle
(Becton-Dickinson). On the day of the experiment, mice
were placed in containers and habituated for 15 min.
Then, the behavior of the mice was video recorded 30
min before (baseline behavior), and 30 min after, the
chemical was injected. The experimenter was present
briefly - once to start the video recording, and once
later to administer the chemical. The video recording
was subsequently played back and scratching bouts or
wipes were counted. A scratching bout was initiated by
lifting of the hind paw to the region to be scratched,
and ended when the hind paw was returned to the floor
or to the mouth for licking. Only the bouts or wipes to
the shaved region were counted.
Statistical Analyses of Pain and Itch Behaviors
All data are presented as mean +/- SEM. Hot plate, von
Frey, and Randall-Selitto data was calculated as the aver-
age of two independent tests performed on two conse-
cutive days. For formalin and itching behaviors, the
mean numbers of licking/biting and scratching bouts,
respectively, and SEM during the period were calculated
for each group. The difference between the mutant and
control group was subjected to a Student’stt e s t( t w o -
sample assuming unequal variance), with p < 0.05 con-
sidered statistically significant.
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